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SCIENTIFIC OPINION 
Scientific Opinion on Flavouring Group Evaluation 303, Revision 1 
(FGE.303Rev1): Spilanthol from chemical group 301 
EFSA Panel on Food Contact Materials, Enzymes, Flavourings and Processing Aids 
(CEF)2, 3 
European Food Safety Authority (EFSA), Parma, Italy 
ABSTRACT  
The Panel on Food Contact Materials, Enzymes, Flavourings and Processing Aids of the European Food Safety 
Authority was requested to evaluate the flavouring substance spilanthol [FL-no: 16.121] in Flavouring Group 
Evaluation 303, Revision 1, using the Procedure according to Commission Regulation (EC) No 1565/2000. This 
revision is made as new 90 days toxicity data have been submitted for spilanthol [FL-no: 16.121]. The substance 
was considered not to have genotoxic potential. The substance was evaluated through a stepwise approach that 
integrates information on structure-activity relationships, intake from current uses, toxicological threshold of 
concern, and available data on metabolism and toxicity. The Panel concluded that spilanthol [FL-no: 16.121] 
does not give rise to safety concern at its level of dietary intake, estimated on the basis of the Maximum Survey-
derived Daily Intake (MSDI) approach. Besides the safety assessment of the flavouring substance, the 
specifications for the material of commerce have also been considered. Adequate specifications including 
complete purity criteria and identity for the material of commerce have been provided for the candidate 
substance. 
© European Food Safety Authority, 2015 
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SUMMARY  
The Scientific Panel on Food Contact Materials, Enzymes, Flavourings and Processing Aids (the 
Panel) was asked to provide scientific advice to the Commission on the implications for human health 
of chemically defined flavouring substances used in or on foodstuffs in the Member States. In 
particular, the Panel was requested to re-evaluate the flavouring substance in the Flavouring Group 
Evaluation 303Rev1, using the Procedure as referred to in the Commission Regulation (EC) No 
1565/2000. The flavouring substance belongs to chemical group 30, Annex I of the Commission 
Regulation (EC) No 1565/2000. 
The present revision of FGE.303, FGE.303Rev1 includes a re-evaluation of spilanthol [FL-no: 16.121] 
as additional data, from a 90-day dietary rat study have become available. 
The candidate substance spilanthol [FL-no: 16.121] is a branched chain unsaturated aliphatic amide.  
The specifications provided specify the stereoisomeric composition. Spilanthol is assigned to 
structural class III, according to the decision tree approach presented by Cramer et al., 1978.  
According to the Flavour Industry spilanthol has been identified in the plant Spilanthes oleracea, 
which is used in some countries as a spice. 
In its evaluation, the Panel as a default used the ‘Maximised Survey-derived Daily Intake’ (MSDI) 
approach to estimate the per capita intakes of the flavouring substances in Europe. However, when the 
Panel examined the information provided by the European Flavouring Industry on the use levels in 
various foods, it appeared obvious that the MSDI approach in a number of cases would grossly 
underestimate the intake by regular consumers of products flavoured at the use level reported by the 
Industry, especially in those cases where the annual production values were reported to be small. In 
consequence, the Panel had reservations about the data on use and use levels provided and the intake 
estimates obtained by the MSDI approach.  
In the absence of more precise information that would enable the Panel to make a more realistic 
estimate of the intakes of the flavouring substances, the Panel has decided also to perform an estimate 
of the daily intakes per person using a ‘modified Theoretical Added Maximum Daily Intake’ 
(mTAMDI) approach based on the normal use levels reported by Industry. In those cases where the 
mTAMDI approach indicated that the intake of a flavouring substance might exceed its corresponding 
threshold of concern, the Panel decided not to carry out a formal safety assessment using the 
Procedure. In these cases the Panel requires more precise data on use and use levels. 
No in vitro or in vivo data on genotoxicity are available for the candidate substance spilanthol. 
However, for the two structurally related substances deca-(2E, 4E)-dienoic acid isobutyl-amide [FL-
no: 16.091] and N-cyclopropyl (2E,6Z)-nonadienamide [FL-no: 16.093] negative genotoxicity studies 
are available. The Panel therefore concluded that the lack of genotoxicity data for the candidate 
substance spilanthol [FL-no: 16.121] does not preclude the evaluation of this aliphatic amide using the 
Procedure. 
The candidate substance cannot be anticipated to be metabolised to innocuous products. 
According to the default MSDI approach, spilanthol has an intake in Europe of 24 µg/capita/day, 
which is below the threshold of concern value for structural class III substances of 90 µg/person/day. 
When the estimated intake was based on the mTAMDI approach it is 670 µg/person/day for the 
candidate substance, which is above the threshold of concern for a structural III substance of 
90 µg/person/day. Therefore more reliable exposure data are required. On the basis of such additional 
data, the flavouring substance should be reconsidered using the Procedure. Subsequently, additional 
data might become necessary. 
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Since the publication of FGE.303, a 90-day study in rats has become available for spilanthol [FL-no: 
16.121], providing a NOAEL of 23.4 mg/kg bw/day. The estimated daily per capita intake for the 
candidate substance of 24 µg corresponds to 0.4 µg/kg bw/day at a body weight of 60 kg. Thus, a 
margin of safety of 5.9 × 104 can be calculated.  
In order to determine whether the conclusion for the candidate substance can be applied to the material 
of commerce, it is necessary to consider the available specifications. Adequate specifications including 
complete purity criteria and identity for the material of commerce have been provided for the 
flavouring substance.  
Therefore, the Panel concluded that spilanthol [FL-no: 16.121] would not present a safety concern at 
the estimated level of intake based on the MSDI approach. 
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BACKGROUND AS PROVIDED BY THE EUROPEAN COMMISSION 
The use of flavourings is regulated under Regulation (EC) No 1334/2008 of the European Parliament 
and Council of 16 December 20084 on flavourings and certain food ingredients with flavouring 
properties for use in and on foods. On the basis of Article 9(a) of this Regulation, an evaluation and 
approval are required for flavouring substances. 
The Union list of flavourings and source materials was established by Commission Implementing 
Regulation (EC) No 872/20125. The list contains flavouring substances for which the scientific 
evaluation should be completed in accordance with Commission Regulation (EC) No 1565/20006. 
EFSA has evaluated the flavouring substance spilanthol [FL-no: 16.121] in the flavouring group 
evaluation 303 (FGE.303). The opinion was adopted on 3 February 2011. EFSA concluded in its 
opinion that additional data on the chemically defined material are required as a 28 day study is not 
considered sufficient to derive a No Observed Adverse Effect Level (NOAEL). 
The requested additional data (90-day dietary study in rats) have now been submitted by the applicant. 
The Commission asks EFSA to evaluate this new information and depending on the outcome proceed 
to the full evaluation of the flavouring substance. 
TERMS OF REFERENCE AS PROVIDED BY THE EUROPEAN COMMISSION 
The European Commission requests EFSA to carry out a safety assessment on the following 
flavouring substance: spilanthol [FL-no: 16.121] in accordance with Commission Regulation (EC) No 
1565/2000. 
                                                     
4
  Regulation (EC) No 1334/2008 of the European Parliament and of the Council of 16 December 2008 on flavourings and 
certain food ingredients with flavouring properties for use in and on foods and amending Council Regulation (EEC) No 
1601/91, Regulations (EC) No 2232/96 and (EC) No 110/2008 and Directive 2000/13/EC. OJ L 354, 31.12.2008, p. 34–50. 
5
  Commission implementing Regulation (EU) No 872/2012 of 1 October 2012 adopting the list of flavouring substances 
provided for by Regulation (EC) No 2232/96 of the European Parliament and of the Council, introducing it in Annex I to 
Regulation (EC) No 1334/2008 of the European Parliament and of the Council and repealing Commission Regulation (EC) 
No 1565/2000 and Commission Decision 1999/217/EC. OJ L 267, 2.10.2012, p, 1–161. 
6 
 Commission Regulation No 1565/2000 of 18 July 2000 laying down the measures necessary for the adoption of an 
evaluation programme in application of Regulation (EC) No 2232/96. OJ L 180, 19.7.2000, p. 8–16. 
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ASSESSMENT 
1. History of the Evaluation  
In FGE.303, the Panel considered that additional toxicity data were needed for spilanthol [FL-no: 
16.121] evaluated through the Procedure, as no adequate toxicity study was available from which a no 
observed adverse effect level (NOAEL) could be established, neither on  spilanthol nor on  structurally 
related substances. 
FGE Opinion 
adopted by 
EFSA 
Link No. of 
candidate 
substances 
FGE.303 3 February 2011 http://www.efsa.europa.eu/en/efsajournal/pub/1995.htm 1 
FGE.303Rev1   1 
 
The present Revision of FGE.303, FGE.303Rev1 includes a re-evaluation of spilanthol [FL-no: 
16.121], as a 90-day dietary rat study with the flavouring substance has become available (Bauter, 
2012; Flavour Industry, 2013). Additional information on possible neurotoxicity of spilanthol has also 
been submitted (Kadir et al., 1989; Flavour Industry, 2014). A search in the open literature did not 
reveal any pertinent new information on spilanthol. 
2. Presentation of the Substances in Flavouring Group Evaluation 303, Revision 1 
2.1. Description 
The present Flavouring Group Evaluation 303, Revision 1 (FGE.303Rev1), using the Procedure as 
referred to in the Commission Regulation (EC) No 1565/2000 (the Procedure – shown in schematic 
form in Appendix A of this FGE), deals with one flavouring substance (candidate substance) from 
chemical group 30 of Annex I of Commission Regulation (EC) No 1565/2000 (EC, 2000).  
The structural formula of the candidate substance together with its chemical name, FLAVIS- (FL-), 
Chemical Abstract Service- (CAS-), Council of Europe- (CoE-) and Flavor and Extract Manufacturers 
Association- (FEMA-) numbers, is listed in Table 1. 
The outcome of the safety evaluation of the candidate substance, spilanthol [FL-no: 16.121] is 
summarised in Table 4 and the hydrolysis products of the candidate substance are listed in Table 5.  
Spilanthol is a branched chain unsaturated aliphatic amide and is structurally closely related to three 
flavouring substances [FL-no: 16.091, 16.093 and 16.094] evaluated at the 65th JECFA meeting 
(JECFA, 2006b) in the group of ‘Aliphatic and aromatic amines and amides’ and considered by the 
Panel in FGE.86Rev1. Since the publication of FGE.303, two of the JECFA evaluated substances, N-
cyclopropyl (2E,6Z)-nonadienamide [FL-no: 16.093] and N-ethyl (2E,6Z)-nonadienamide [FL-no: 
16.094] are no longer supported for use as flavouring substances in the European Union (DG SANCO, 
2012) The names and structures of the supporting flavouring substance and the two structurally related 
substances are listed in Table 6, together with their JECFA evaluation status.  
2.2. Stereoisomers 
It is recognised that geometrical and optical isomers of substances may have different properties. Their 
flavour may be different; they may have different chemical properties resulting in possible variability 
in their absorption, distribution, metabolism, elimination and toxicity. Thus, information must be 
provided on the configuration of the flavouring substance, i.e. whether it is one of the 
geometrical/optical isomers, or a defined mixture of stereoisomers. The available specifications of 
purity will be considered in order to determine whether the safety evaluation carried out for candidate 
substances for which stereoisomers may exist can be applied to the material of commerce. Flavouring 
Flavouring Group Evaluation 303 Revision 1
 
EFSA Journal 2015;13(1):3995 7
substances with different configurations should have individual chemical names and codes (CAS 
number, FLAVIS number etc.). 
Spilanthol [FL-no: 16.121] can exist as geometrical stereoisomers due to the presence of double 
bonds. The name spilanthol specifies the (2E,6Z,8E) stereoisomer (see Table 1). Information on the 
proportions of the geometrical isomers has been provided (Flavour Industry, 2009) (see Table 1). 
2.3. Natural Occurrence in Food 
According to TNO, the candidate substance spilanthol [FL-no: 16.121] has not been reported to occur 
naturally in any food items (TNO, 2010). Spilanthol has been identified in Spilanthes oleracea, which 
according to Flavour Industry is used as a spice in some countries (Yasuda et al., 1980; Molinatorres 
et al., 1996; Ramsewak et al., 1999). 
3. Specifications 
Purity criteria for the candidate substance have been provided by the Flavour Industry (Flavour 
Industry, 2009) (Table 1). 
Judged against the requirements in Annex II of Commission Regulation (EC) No 1565/2000 (EC, 
2000), this information is adequate for the candidate substance (see Section 2.2 and Table 1). 
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Table 1:  Specification Summary of the Substance in the FGE.303Rev1 
FL-no 
JECFA-
no 
Name Structural formula FEMA no 
CoE no 
CAS no 
 
Phys.form 
Mol.formula 
Mol.weight 
Solubility 
(a)
 
Solubility 
in ethanol 
(b)
 
Boiling point, °C (c) 
Melting point, °C 
ID test 
Assay minimum 
Refrac. 
Index (d) 
Spec.gravity 
(e)
 
Specification comments 
16.121 
2077 
Spilanthol 
N
H
O
 
4668 
 
25394-57-4 
Liquid 
C14H23NO 
221.35 
Insoluble 
Soluble 
140-160 (13 Pa) 
 
IR NMR MS 
74 % 
1.491-1.541 
0.945-0.945 
Synonym: (2E,6Z,8E)-N-
(2-Methylpropyl)-2,6,8-
decatrienamide. 
Secondary compounds: 
16.7 % (2E,6E,8E)-, 5.8 % 
(2E,6E,8Z)-, 0.9 % 
(2Z,6Z,8E)-, 0.3 % 
(2E,6E,8E)-, 0.8 % 
(2Z,6Z,8Z)-isomer, 1.6 % 
other isomers. 
(a): Solubility in water, if not otherwise stated. 
(b): Solubility in 95 % ethanol, if not otherwise stated. 
(c): At 1013.25 hPa, if not otherwise stated. 
(d): At 20°C, if not otherwise stated. 
(e): At 25°C, if not otherwise stated. 
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4. Intake Data 
Annual production volumes of the flavouring substances as surveyed by the Industry can be used to 
calculate the ‘Maximised Survey-derived Daily Intake’ (MSDI) by assuming that the production figure 
only represents 60 % of the use in food due to underreporting and that 10 % of the total EU population 
are consumers (SCF, 1999). 
However, the Panel noted that due to year-to-year variability in production volumes, to uncertainties in 
the underreporting correction factor and to uncertainties in the percentage of consumers, the reliability 
of intake estimates on the basis of the MSDI approach is difficult to assess. 
The Panel also noted that in contrast to the generally low per capita intake figures estimated on the 
basis of this MSDI approach, in some cases the regular consumption of products flavoured at use 
levels reported by the Flavour Industry in the submissions would result in much higher intakes. In 
such cases, the human exposure thresholds below which exposures are not considered to present a 
safety concern might be exceeded. 
Considering that the MSDI model may underestimate the intake of flavouring substances by certain 
groups of consumers, the SCF recommended also taking into account the results of other intake 
assessments (SCF, 1999). 
One of the alternatives is the ‘Theoretical Added Maximum Daily Intake’ (TAMDI) approach, which 
is calculated on the basis of standard portions and upper use levels (SCF, 1995) for flavourable 
beverages and foods in general, with exceptional levels for particular foods. This method is regarded 
as a conservative estimate of the actual intake by most consumers because it is based on the 
assumption that the consumer regularly eats and drinks several food products containing the same 
flavouring substance at the upper use level. 
One option to modify the TAMDI approach is to base the calculation on normal rather than upper use 
levels of the flavouring substances. This modified approach is less conservative (e.g., it may 
underestimate the intake of consumers being loyal to products flavoured at the maximum use levels 
reported) (EC, 2000). However, it is considered as a suitable tool to screen and prioritise the 
flavouring substances according to the need for refined intake data (EFSA, 2004). 
4.1. Estimated Daily per Capita Intake (MSDI Approach) 
The intake estimation is based on the Maximised Survey-derived Daily Intake (MSDI) approach, 
which involves the acquisition of data on the amounts used in food as flavourings (SCF, 1999). These 
data are derived from surveys on annual production volumes in Europe. These surveys were conducted 
in 1995 by the International Organization of the Flavour Industry, in which flavour manufacturers 
reported the total amount of each flavouring substance incorporated into food sold in the EU during 
the previous year (IOFI, 1995). The intake approach does not consider the possible natural occurrence 
in food. 
Average per capita intake (MSDI) is estimated on the assumption that the amount added to food is 
consumed by 10 % of the population7 (Eurostat, 1998). This is derived for candidate substances from 
estimates of annual volume of production provided by Industry and incorporates a correction factor of 
0.6 to allow for incomplete reporting (60 %) in the Industry surveys (SCF, 1999). 
The anticipated annual volume of production of the candidate substance spilanthol [FL-no: 16.121] in 
the present Flavouring Group Evaluation (FGE.303Rev1) from use as flavouring substance in Europe 
has been reported to be approximately 200 kg (Flavour Industry, 2009). For the supporting substance 
[FL-no: 16.091] the annual volume of production is 93 kg in Europe (IOFI, 2013). 
                                                     
7
  EU figure 375 millions. This figure relates to EU population at the time for which production data are available, and is 
consistent (comparable) with evaluations conducted prior to the enlargement of the EU. No production data are available 
for the enlarged EU. 
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Based on the annual volume of production reported for the candidate substance, the daily per capita 
intake in the EU from use as a flavouring substance is 24 µg (Table 4). 
4.2. Intake Estimated on the Basis of the Modified TAMDI (mTAMDI) 
The method for calculation of modified Theoretical Added Maximum Daily Intake (mTAMDI) values 
is based on the approach used by SCF up to 1995 (SCF, 1995). 
The assumption is that a person may consume a certain amount of flavourable foods and beverages per 
day. 
Information on food categories and normal and maximum use levels8,9 for spilanthol [FL-no: 16.121] 
was submitted by the Flavour Industry (Flavour Industry, 2009). The candidate substance is used in 
flavoured food products divided into the food categories outlined in Annex III of the Commission 
Regulation (EC) No 1565/2000 (EC, 2000), as shown in Table 2. For the present calculation of the 
mTAMDI, the reported normal use levels were used. In the case where different use levels were 
reported for different food categories the highest reported normal use level was used. 
Table 2:  Use of the Candidate Substance 
Food 
category 
Description Flavouring used 
01.0 Dairy products, excluding products of category 2 Yes 
02.0 Fats and oils, and fat emulsions (type water-in-oil) No 
03.0 Edible ices, including sherbet and sorbet Yes 
04.1 Processed fruits Yes 
04.2 Processed vegetables (incl. mushrooms & fungi, roots & tubers, pulses 
and legumes), and nuts & seeds 
No 
05.0 Confectionery Yes 
06.0 Cereals and cereal products, incl. flours & starches from roots & 
tubers, pulses & legumes, excluding bakery 
Yes 
07.0 Bakery wares No 
08.0 Meat and meat products, including poultry and game No 
09.0 Fish and fish products, including molluscs, crustaceans and 
echinoderms  
Yes 
10.0 Eggs and egg products No 
11.0 Sweeteners, including honey No 
12.0 Salts, spices, soups, sauces, salads, protein products etc. Yes 
13.0 Foodstuffs intended for particular nutritional uses No 
14.1 Non-alcoholic ("soft") beverages, excl. dairy products Yes 
14.2 Alcoholic beverages, incl. alcohol-free and low-alcoholic counterparts Yes 
15.0 Ready-to-eat savouries Yes 
16.0 Composite foods (e.g. casseroles, meat pies, mincemeat) – foods that 
could not be placed in categories 1 – 15 
Yes 
 
According to the Flavour Industry the normal use levels for the candidate substance are in the range of 
0.25–10 mg/kg food, and the maximum use levels are in the range of 1–25 mg/kg (Flavour Industry, 
2009) (see Table B.1.2, Annex B). 
The mTAMDI value is 670 µg/person/day for the candidate substance from structural class III. 
                                                     
8
 ‘Normal use’ is defined as the average of reported usages and ‘maximum use’ is defined as the 95th percentile of reported 
usages (EFFA, 2002). 
9
 The normal and maximum use levels in different food categories (EC, 2000) have been extrapolated from figures derived 
from 12 model flavouring substances (EFFA, 2004). 
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For detailed information on use levels and intake estimations based on the mTAMDI approach, see 
Section 7 and Annex B. 
5. Absorption, Distribution, Metabolism and Elimination 
Specific information regarding absorption, distribution, metabolism and excretion is not available for 
the candidate substance.  
The candidate substance is like other aliphatic amides anticipated to be absorbed from the 
gastrointestinal tract and expected to be at least partly hydrolysed (Bray et al., 1949) to polar 
metabolites which are eliminated in the urine or bile (James, 1974; Schwen, 1982). Hydrolysis of the 
amide bond is reported as a metabolic pathway for amides e.g. dihydrocapsaicin and piperine in vivo 
in rats. However, complete hydrolysis of the candidate substance to innocuous metabolites cannot be 
anticipated (Kawada and Iwai, 1985; Bhat and Chandrasekhara, 1987) therefore the substance should 
be evaluated via the B side of the Procedure. 
6. Application of the Procedure for the Safety Evaluation of Flavouring Substances 
The application of the Procedure is based on intakes estimated on the basis of the MSDI approach. 
Where the mTAMDI approach indicates that the intake of a flavouring substance might exceed its 
corresponding threshold of concern, a formal safety assessment is not carried out using the Procedure. 
In these cases the Panel requires more precise data on use and use levels. For comparison of the intake 
estimations based on the MSDI approach and the mTAMDI approach, see Section 6. 
For the safety evaluation of the candidate substance spilanthol [FL-no: 16.121] from chemical group 
30 the Procedure as outlined in Annex I was applied, based on the MSDI approach. The stepwise 
evaluation of the substance is summarised in Table 4. 
Step 1 
Spilanthol [FL-no: 16.121] is classified into structural class III according to the decision tree approach 
by Cramer et al. (Cramer et al., 1978). 
Step 2 
The candidate substance cannot be anticipated to be metabolised to innocuous products and thus the 
evaluation proceeds via the B-side of the Procedure. 
Step B3 
The estimated daily per capita intake of the candidate substance is 24 µg, which is below the threshold 
for its structural class of 90 µg/person/day (class III). Accordingly, the evaluation of the substance 
proceeds to step B4 of the Procedure. 
Step B4 
For the candidate substance spilanthol [FL-no: 16.121], a NOAEL of 23.4 mg/kg bw/day from a 
multiple dose 90-day oral toxicity study in rats could be derived (Bauter, 2012). The estimated daily 
per capita intake of 24 µg corresponds to 0.4 µg/kg bw/day at a body weight of 60 kg. Thus, a margin 
of safety of 5.9 x 104 can be calculated. The Panel agrees that this provides a sufficient safety margin 
and that the flavouring substance can be concluded at step B4 of the Procedure to be of no safety 
concern. 
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7. Comparison of the Estimated Intake Based on the MSDI and the mTAMDI 
Approaches 
When the estimated intake is based on the mTAMDI approach, the value for the structural class III 
substance, spilanthol is 670 µg/person/day. 
Thus, for the candidate substance further information is required. This would include more reliable 
intake data and then, if required, additional toxicological data. 
For comparison of the MSDI and mTAMDI values, see Table 3. 
Table 3:  Estimated Intakes Based on the MSDI and the mTAMDI Approaches 
FL-no EU Register name MSDI 
(µg/capita/day) 
mTAMDI 
(µg/person/day) 
Structural 
class 
Threshold of 
concern 
(µg/person/day) 
16.121 Spilanthol 24 670 Class III 90 
 
8. Considerations of Combined Intakes from Use as Flavouring Substances 
Because of structural similarities of candidate and the supporting substances, it can be anticipated that 
many of the flavourings are metabolised through the same metabolic pathways and that the 
metabolites may affect the same target organs. Further, in case of combined exposure to structurally 
related flavourings, the pathways could be overloaded. Therefore, combined intake should be 
considered. As flavourings not included in this FGE may also be metabolised through the same 
pathways, the combined intake estimates presented here are only preliminary. Currently, the combined 
intake estimates are only based on MSDI exposure estimates, although it is recognised that this may 
lead to underestimation of exposure. After completion of all FGEs, this issue should be readdressed. 
The total estimated combined daily per capita intake of structurally related flavourings is estimated by 
summing the MSDI for individual substances. 
On the basis of the reported annual production volume in Europe (Flavour Industry, 2009), the 
estimated daily per capita intake as flavouring of spilanthol [FL-no: 16.121] belonging to structural 
class III is 24 µg. This value does not exceed the threshold of concern for structural class III of 90 
µg/person/day.  
The candidate substance is structurally related to one supporting flavouring substance evaluated by the 
JEFCA at its 65th meeting (JECFA, 2006a). Based on reported production volumes, European per 
capita intakes (MSDI) could be estimated for the supporting substance, deca-(2E,4E)-dienioc acid 
isobutyl-amide [FL-no: 16.091]. The total combined intake of the candidate and supporting substance 
is 35 µg/capita/day, which does not exceed the thresholds of concern for structural class III 
substances.  
9. Toxicity 
9.1. Acute Toxicity 
No data on mammals are available for the candidate substance or supporting substances. 
The substance was earlier demonstrated to be toxic to Anopheles larvae as well as to adult houseflies 
(Jacobson, 1957 as quoted in (Kadir et al., 1989)). Later it was further shown to be acute toxic (LD50 
2.46 µg/g insect) also to adult American cockroach (Periplaneta Americana L.) (Kadir et al., 1989). In 
the latter study spilanthol shows a higher toxicity than three conventional insecticides representing 
various classes, namely carbaryl, bioresmethrin and lindane. Electrophysiological studies indicated 
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immediate hyperexitation followed by complete inhibition of the cockroach central nerve activity 
(Kadir et al., 1989). 
On the basis of the absence of clinical signs indicating neurotoxicity in the 90-day study the Panel 
considered the acute toxicity studies using insect’s surface exposure in acetone solution directly on the 
chitin exoskeleton as not being of relevance to humans. 
9.2. Subacute, Subchronic, Chronic and Carcinogenicity Studies 
Subacute toxicity data are available for the candidate substance spilanthol [FL-no: 16.121] but not for 
the supporting substances of the present flavouring group. 
Only a summary is available on a 28-day study in rats. In the study, groups of five male and five 
female Sprague-Dawley Aai:N(SD)BR rats were maintained on a diet containing 0, 130, 1300 or 
13000 mg/kg gold root extract of unknown purity. As spilanthol comprises approximately 50 % of the 
composition of gold root extract, the effective dietary concentration of spilanthol was about 5.5, 57 
and 572 mg/kg body weight (bw)/day for males and 6.5, 64 and 629 mg/kg bw/day for females, 
respectively. The animals were observed daily for clinical signs and mortality. Individual body 
weights and food consumption were recorded weekly. On day 29 of the study, blood was sampled 
from all animals for haematological and clinical chemistry analysis, and gross necropsis were 
performed on all rats. During the study, no deaths or clinical signs of toxicity were observed in any 
test group. The authors concluded that the NOAEL for spilanthol was 572 mg/kg bw/day based on the 
assumption of the concentration above (Moore, 2002). This result was used at the JECFA evaluation 
of three supporting substances [FL-no: 16.091, 16.093 and 16.094]. However, the Panel does not 
consider this study appropriate for deriving a NOAEL for chronic effects to be used at step B4 of the 
Procedure for these substances, and accordingly additional data are required. According to the practice 
of the Panel, a minimum requirement to provide an adequate NOAEL for flavourings in the Procedure 
is a 90-day study. 
A new 90-day dietary study is now available on spilanthol [FL-no: 16.121]. 
A 90-day study was performed with spilanthol [FL-no: 16.121] (Bauter, 2012). The study was 
performed according to OECD guideline (TG 408). Four groups of rats (10/sex/dietary intake level) of 
male and female CRL Sprague-Dawley CD® IGS rats were fed a diet designed to provide 0 (dietary 
control), 180, 360 and 1200 mg/kg of spilanthol in the feed (Bauter, 2012). These dietary levels 
correspond to the measured daily intake of 0, 11.8, 23.4 and 80.3 mg/kg bw for males and 0, 14.3, 27.9 
and 92.5 mg/kg bw for females. Spilanthol was stable during the course of the study with overall 
average concentrations of 92.4, 95.3 and 99.5 %, respectively for 180, 360 and 1200 mg/kg dietary 
levels. Clinical observations of toxicity were performed on day 0 and weekly throughout the study 
until sacrifice. Animals were weighed on day 0 at the start of the study and weekly thereafter. Food 
consumption and efficiency were measured and calculated weekly. Blood chemistry and haematology 
were performed on blood drawn via sublingual bleed during week 12 after overnight fast. Urine was 
collected during the 15 hours prior to the blood draw. At termination of the study all survivors were 
sacrificed and subject to full necropsy.  
No substance-related mortalities, no gross observations and no macroscopic findings at sacrifice were 
attributed to spilanthol in the diet. Decreases in food consumption of approximately 20 % were 
observed at all dose levels. In the male top dose group this was accompanied by a decreased body 
weight and decreased body weight gain. Dose-dependent decreases in food consumption in females 
did not result in reduced body weight or body weight gain. No adverse effects were observed in 
clinical chemistry or urinalysis. The only microscopic finding related to spilanthol was a minimal 
hypertrophy of the submandibular salivary gland acini in males and females of the top dose only.  
Overall, considering both sexes, there were no significant changes in absolute and/or relative organ 
weights in the low and mid dosed groups compared with control as a result of test substance exposure. 
However, decreases in absolute but also relative adrenal gland- and liver weights were observed in 
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male rats in a dose-dependent manner reaching statistically significant at the highest dose. In addition, 
in this group statistically significant decreases in absolute heart and kidney weights and an increased 
brain-to-body weight ratio compared with control were seen. However, none of these effects were 
correlated with clinical or histopathological findings,  therefore, they were considered non-adverse. In 
general, substance administration appeared to affect males more than females. 
Based on the fact that no statistically significant changes in absolute or relative organ weights were 
seen in the low and mid dose groups, and based on the hypertrophy of salivary gland in both sexes in 
the highest dose, but not in the mid dose group, the NOAEL for spilanthol in the diet is set to 360 
mg/kg feed (mid dose), which corresponds to calculated intakes of 23.4 mg/kg bw/day in males and 
27.9 mg/kg bw/day in females (Bauter, 2012).  
Although specific functional neurological tests were not conducted, a large set of observations were 
made twice daily in the 90-day study including among others occurrence of secretions, excretions and 
autonomic activity (e.g. lacrimation, piloerection, pupil size, unusual respiration pattern), changes in 
gate, posture, response to handling, and the presence of clonic or tonic movements etc. No treatment 
related effects were identified at these observations.  
Repeated dose toxicity data are summarised in Table 7. 
9.3. Developmental / Reproductive Toxicity Studies 
No data on developmental toxicity and reproductive toxicity are available for the candidate substance 
or supporting substances. 
9.4. Genotoxicity Studies 
No in vitro or in vivo data on genotoxicity are available for the candidate substance spilanthol. 
However, for two of the supporting substances [FL-no: 16.091 and 16.093] negative genotoxicity 
studies are available. The Panel therefore concluded that the lack of genotoxicity data for spilanthol 
[FL-no: 16.121] does not preclude the evaluation of this aliphatic amide using the Procedure.  
Genotoxicity data are summarised in Table 8. 
CONCLUSION  
The candidate substance spilanthol [FL-no: 16.121] is a branched chain unsaturated aliphatic amide 
from chemical group 30. 
This revision is made due to the submission of new toxicological data from a 90 days study with the 
substance spilanthol [FL-no: 16.121].  
The substance has been presented with specification of the stereoisomeric composition and it is 
assigned to structural class III, according to the decision tree approach presented by Cramer et al., 
1978. Spilanthol has been identified in the plant Spilanthes oleracea, which is used in some countries 
as a spice according to the Flavour Industry. 
No in vitro or in vivo data on genotoxicity are available for the candidate substance spilanthol. 
However, for the two structurally related substances [FL-no: 16.091 and 16.093] negative genotoxicity 
studies are available. The Panel therefore considers that for the candidate substance spilanthol [FL-no: 
16.121] the lack of genotoxicity data does not preclude the evaluation of this aliphatic amide using the 
Procedure.  
The candidate substance cannot be anticipated to be metabolised to innocuous products. 
According to the default MSDI approach, spilanthol has an intake in Europe of 24 µg/capita/day, 
which is below the threshold of concern value for structural class III (90 µg/person/day). 
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When the estimated intake is based on the mTAMDI approach it is 670 µg/person/day for the 
candidate substance from structural class III, which is above the threshold of concern for structural III 
of 90 µg/person/day. Therefore more reliable exposure data are required. On the basis of such 
additional data, the flavouring substance should be reconsidered using the Procedure. Subsequently, 
additional data might become necessary. 
Since the publication of FGE.303, a 90-day study in the rat has become available for the candidate 
substance spilanthol [FL-no: 16.121], providing a NOAEL of 23.4 mg/kg bw/day. The estimated daily 
per capita intake for the candidate substance of 24 µg corresponds to 0.4 µg/kg bw/day at a body 
weight of 60 kg. Thus, a margin of safety of 5.9 x 104 can be calculated.  
In order to determine whether the conclusion for the candidate substance can be applied to the material 
of commerce, it is necessary to consider the available specifications. Adequate specifications including 
complete purity criteria and identity for the material of commerce have been provided for the 
flavouring substance.  
Therefore, the Panel concluded that spilanthol [FL-no: 16.121] would not present a safety concern at 
the estimated level of intake based on the MSDI approach. 
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Table 4:  Summary of Safety Evaluation Applying the Procedure 
FL-no EU Register name Structural formula MSDI (a) 
(µg/capita/day) 
Class (b) 
Evaluation procedure path 
(c)
 
Outcome on the 
named compound (d),(e) 
Outcome on the 
material of 
commerce 
(f),(g),(h)
 
Evaluation 
remarks 
16.121 
2077 
Spilanthol 
N
H
O
 
24 
 
Class III 
B3: Intake below threshold, 
B4: Adequate NOAEL exists 
d f  
(a): EU MSDI: Amount added to food as flavour in (kg / year) × 10E9 / (0.1 x population in Europe (= 375 × 10E6) × 0.6 × 365)  =  µg/capita/day. 
(b): Thresholds of concern: Class I = 1800 µg/person/day, Class II = 540 µg/person/day, Class III = 90 µg/person/day. 
(c): Procedure path A substances can be predicted to be metabolised to innocuous products.  Procedure path B substances cannot. 
(d): No safety concern based on intake calculated by the MSDI approach of the named compound. 
(e): Data must be available on the substance or closely related substances to perform a safety evaluation. 
(f): No safety concern at the estimated level of intake of the material of commerce meeting the specification requirement (based on intake calculated by the MSDI approach). 
(g): Tentatively regarded as presenting no safety concern (based on intake calculated by the MSDI approach) pending further information on the purity of the material of commerce and/or 
information on stereoisomerism. 
(h): No conclusion can be drawn due to lack of information on the purity of the material of commerce. 
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Table 5:  Evaluation Status of Hydrolysis Products of Candidate Substance 
FL-no EU Register name 
JECFA no 
Structural formula SCF status (a) 
JECFA status (b) 
CoE status (c) 
EFSA status 
Structural class (d) 
Procedure path (JECFA) (e) 
Comments 
 2,6,8-Triendecanoic 
acid 
OH
O
 
Not evaluated as flavouring 
substance. 
Not evaluated as flavouring 
substance. 
Not evaluated as flavouring 
substance. 
11.002 Isobutylamine 
1583 NH2
 
 
No safety concern (JECFA, 
2008) 
Category A (CoE, 1992) 
 
Class I 
A3: Intake below threshold 
 
(a): Category 1: Considered safe in use   Category 2: Temporarily considered safe in use   Category 3: Insufficient data to provide assurance of safety in use   Category 4: Not acceptable due to 
evidence of toxicity. 
(b): No safety concern at estimated levels of intake. 
(c): Category A: Flavouring substance, which may be used in foodstuffs Category B: Flavouring substance which can be used provisionally in foodstuffs. 
(d): Threshold of concern: Class I = 1800 µg/person/day, Class II = 540 µg/person/day, Class III = 90 µg/person/day. 
(e): Procedure path A substances can be predicted to be metabolised to innocuous products. Procedure path B substances cannot. 
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Table 6:  Summary of Safety Evaluation of Supporting Substance 
FL-no EU Register name Structural formula FEMA no 
CoE no 
CAS no 
JECFA no  
Specification available 
MSDI (EU) (a) 
(µg/capita/day) 
SCF status (b) 
JECFA status (c) 
CoE status (d) 
EFSA Comments 
16.091 Deca-(2E,4E)-dienoic 
acid isobutyl-amide NH
O
 
4148 
 
18836-52-7 
1598 
JECFA specification 
(JECFA, 2005). 
11  
No safety concern 
(JECFA, 2008) 
 
No safety concern at the 
estimated level of intake 
based on the MSDI approach. 
16.093 N-Cyclopropyl (2E,6Z)-
nonadienamide NH
O
 
4087 
 
608514-55-2 
1597 
JECFA specification 
(JECFA, 2005). 
-  
No safety concern 
(JECFA, 2008) 
 
No longer supported by 
Industry (DG SANCO, 2012). 
16.094 N-Ethyl (2E,6Z)-
nonadienamide NH
O
 
4113 
 
608514-56-3 
1596 
JECFA specification 
(JECFA, 2005). 
-  
No safety concern 
(JECFA, 2008) 
 
No longer supported by 
Industry (DG SANCO, 2014). 
(a): EU MSDI: Amount added to food as flavouring substance in (kg / year) × 10E9 / (0.1 × population in Europe (= 375 × 10E6) × 0.6 × 365)  =  µg/capita/day. 
(b): Category 1: Considered safe in use, Category 2: Temporarily considered safe in use, Category 3: Insufficient data to provide assurance of safety in use, Category 4: Not acceptable due to 
evidence of toxicity. 
(c): No safety concern at estimated levels of intake. 
(d): Category A: Flavouring substance, which may be used in foodstuffs, Category B: Flavouring substance which can be used provisionally in foodstuffs. 
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Table 7:  Subacute / Subchronic / Chronic / Carcinogenicity Studies 
Chemical Name  
[FL-no] 
Species; 
Sex 
No./Group 
Route Dose levels 
mg/kg bw/day 
Duration NOAEL 
(mg/kg 
bw/day) 
Reference Comments 
Spilanthol [16.121] Rats, M, F 
5 
Oral M: 5.5, 57, 572  
F: 6.5, 64, 629  
28 days 572 (Moore, 2002) The study is not considered valid. 
The study has not been available. Only a short summary has been 
submitted by Industry. The JECFA evaluation of this study at the 65th 
meeting has also been considered but the Panel did not agree with the 
JECFA that the study is appropiate for deriving a NOAEL. 
Rats, M, F 
3/20 
Diet M:11.8/ 23.4, 80.3  
F: 14.3, 27.9, 92.5  
90 days 23.4 (Bauter, 2012) OECD Guideline study (408). 
 
 
Table 8:  Genotoxicity (in vitro) 
Chemical Name  
[FL-no]* 
Test System Test Object Concentration 
 
Result Reference Comments 
(Deca-(2E,4E)-dienoic acid 
isobutyl-amide [16.091]) 
Reverse Mutation S.typhimurium TA98, TA100, TA102, TA1535, 
TA1537 
5 to 1500 µg/plate(c) Negative(a) (King, 2003)  
 Reverse Mutation S.typhimurium TA98, TA100, TA102, TA1535, 
TA1537 
5 to 5000 µg/plate(d) Negative(b) (King, 2003)  
(N-Cyclopropyl (2E,6Z)-
nonadienamide) 
Reverse Mutation S.typhimurium TA98, TA100, TA1535, TA1537 Up to 5000 µg/plate Negative(a) (Bowles, 
2003) 
 
 Reverse Mutation E.coli WP2 uvrA- Up to 5000 µg/plate Negative(a) (Bowles, 
2003) 
 
*: Supporting or structurally related substance 
(a): With and without S9 metabolic activation. 
(b): With metabolic activation. 
(c): Toxic and precipitates at 1500 µg/plate. 
(d): Toxic and precipitates at 5000 µg/plate. 
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APPENDIX A: PROCEDURE FOR THE SAFETY EVALUATION 
The approach for a safety evaluation of chemically defined flavouring substances as referred to in 
Commission Regulation (EC) No 1565/2000 (EC, 2000), named the ‘Procedure’, is shown in 
schematic form in Figure A.1. The Procedure is based on the Opinion of the Scientific Committee on 
Food expressed on 2 December 1999 (SCF, 1999), which is derived from the evaluation Procedure 
developed by the Joint FAO/WHO Expert Committee on Food Additives at its 44th, 46th and 49th 
meetings (JECFA, 1995; JECFA, 1996; JECFA, 1997; JECFA, 1999). 
The Procedure is a stepwise approach that integrates information on intake from current uses, 
structure-activity relationships, metabolism and, when needed, toxicity. One of the key elements in the 
Procedure is the subdivision of flavourings into three structural classes (I, II, III) for which thresholds 
of concern (human exposure thresholds) have been specified. Exposures below these thresholds are 
not considered to present a safety concern. 
Class I contains flavourings that have simple chemical structures and efficient modes of metabolism, 
which would suggest a low order of oral toxicity. Class II contains flavourings that have structural 
features that are less innocuous, but are not suggestive of toxicity. Class III comprises flavourings that 
have structural features that permit no strong initial presumption of safety, or may even suggest 
significant toxicity (Cramer et al., 1978). The thresholds of concern for these structural classes of 
1800, 540 or 90 µg/person/day, respectively, are derived from a large database containing data on 
subchronic and chronic animal studies (JECFA, 1996). 
In Step 1 of the Procedure, the flavourings are assigned to one of the structural classes. The further 
steps address the following questions: 
• can the flavourings be predicted to be metabolised to innocuous products10 (Step 2)?  
• do their exposures exceed the threshold of concern for the structural class (Step A3 and B3)? 
• are the flavourings or their metabolites endogenous11 (Step A4)?  
• does a NOAEL exist on the flavourings or on structurally related substances (Step A5 and 
B4)? 
In addition to the data provided for the flavouring substances to be evaluated (candidate substances), 
toxicological background information available for compounds structurally related to the candidate 
substances is considered (supporting substances), in order to assure that these data are consistent with 
the results obtained after application of the Procedure.  
The Procedure is not to be applied to flavourings with existing unresolved problems of toxicity. 
Therefore, the right is reserved to use alternative approaches if data on specific flavourings warranted 
such actions. 
 
                                                     
10
  ‘Innocuous metabolic products’: Products that are known or readily predicted to be harmless to humans at the estimated 
intakes of the flavouring agent’ (JECFA, 1997). 
11
  ‘Endogenous substances’: Intermediary metabolites normally present in human tissues and fluids, whether free or 
conjugated; hormones and other substances with biochemical or physiological regulatory functions are not included 
(JECFA, 1997). 
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Figure A.1: Procedure for safety evaluation of chemically defined flavouring substances 
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APPENDIX B: USE LEVELS / MTAMDI 
B.1  Normal and Maximum Use Levels 
For each of the 18 Food categories (Table B.1.1) in which the candidate substances are used, Flavour 
Industry reports a ‘normal use level’ and a ‘maximum use level’ (EC, 2000). According to the Industry 
the ‘normal use’ is defined as the average of reported usages and ‘maximum use’ is defined as the 95th 
percentile of reported usages (EFFA, 2002). The normal and maximum use levels in different food 
categories have been extrapolated from figures derived from 12 model flavouring substances (EFFA, 
2004). 
Table B.1.1 Food categories according to Commission Regulation (EC) No 1565/2000 (EC, 2000) 
Food 
category 
Description 
01.0 Dairy products, excluding products of category 02.0 
02.0 Fats and oils, and fat emulsions (type water-in-oil) 
03.0 Edible ices, including sherbet and sorbet 
04.1 Processed fruit 
04.2 Processed vegetables (incl. mushrooms & fungi, roots & tubers, pulses and legumes), and nuts 
& seeds 
05.0 Confectionery 
06.0 Cereals and cereal products, incl. flours & starches from roots & tubers, pulses & legumes, 
excluding bakery 
07.0 Bakery wares 
08.0 Meat and meat products, including poultry and game 
09.0 Fish and fish products, including molluscs, crustaceans and echinoderms  
10.0 Eggs and egg products 
11.0 Sweeteners, including honey 
12.0 Salts, spices, soups, sauces, salads, protein products, etc. 
13.0 Foodstuffs intended for particular nutritional uses 
14.1 Non-alcoholic ("soft") beverages, excl. dairy products 
14.2 Alcoholic beverages, incl. alcohol-free and low-alcoholic counterparts 
15.0 Ready-to-eat savouries 
16.0 Composite foods (e.g. casseroles, meat pies, mincemeat) – foods that could not be placed in 
categories 01.0–15.0 
The ‘normal and maximum use levels’ are provided by Industry for the candidate substance in the 
present flavouring group (Table B.1.2). 
B.2  mTAMDI Calculations 
The method for calculation of modified Theoretical Added Maximum Daily Intake (mTAMDI) values 
is based on the approach used by SCF up to 1995 (SCF, 1995). The assumption is that a person may 
consume the amount of flavourable foods and beverages listed in Table B.2.1. These consumption 
estimates are then multiplied by the reported use levels in the different food categories and summed 
up.  
Table B.2.1 Estimated amount of flavourable foods, beverages, and exceptions assumed to be 
consumed per person per day (SCF, 1995) 
Class of product category Intake estimate (g/day) 
Beverages (non-alcoholic) 324.0 
Foods 133.4 
Exception a: Candy, confectionery 27.0 
Exception b: Condiments, seasonings 20.0 
Exception c: Alcoholic beverages 20.0 
Exception d: Soups, savouries 20.0 
Exception e: Others, e.g. chewing gum e.g. 2.0 (chewing gum) 
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Table B.1.2 Normal and Maximum use levels (mg/kg) for the candidate substance in FGE.303, Revision 1 (Flavour Industry, 2009). 
FL-no 
Food Categories 
Normal use levels (mg/kg) 
Maximum use levels (mg/kg) 
01.0 02.0 03.0 04.1 04.2 05.0 06.0 07.0 08.0 09.0 10.0 11.0 12.0 13.0 14.1 14.2 15.0 16.0 
16.121 1.25 2.5 
- 
- 
1.25 
2.5 
0.25 
1 
- 
- 
10 
17.5 
1 
3 
- 
- 
- 
- 
0.5 
1.5 
- 
- 
- 
- 
0.75 
1.5 
- 
- 
0.5 
1.5 
1 
3 
0.5 
1.5 
1 
3 
 
Table B.2.2 Distribution of the 18 food categories listed in Commission Regulation (EC) No 1565/2000 (EC, 2000) into the seven SCF food categories used 
for TAMDI calculation (SCF, 1995) 
 Food categories according to Commission Regulation (EC) No1565/2000 Distribution of the seven SCF food categories 
Key Food category Food Beverages Exceptions 
01.0 Dairy products, excluding products of category 02.0 Food   
02.0 Fats and oils, and fat emulsions (type water-in-oil) Food   
03.0 Edible ices, including sherbet and sorbet Food   
04.1 Processed fruit Food   
04.2 Processed vegetables (incl. mushrooms & fungi, roots & tubers, pulses and legumes), and nuts & seeds Food   
05.0 Confectionery   Exception a 
06.0 Cereals and cereal products, incl. flours & starches from roots & tubers, pulses & legumes, excluding 
bakery 
Food   
07.0 Bakery wares Food   
08.0 Meat and meat products, including poultry and game Food   
09.0 Fish and fish products, including molluscs, crustaceans and echinoderms  Food   
10.0 Eggs and egg products Food   
11.0 Sweeteners, including honey   Exception a 
12.0 Salts, spices, soups, sauces, salads, protein products, etc.    Exception d 
13.0 Foodstuffs intended for particular nutritional uses Food   
14.1 Non-alcoholic ("soft") beverages, excl. dairy products  Beverages  
14.2 Alcoholic beverages, incl. alcohol-free and low-alcoholic counterparts   Exception c 
15.0 Ready-to-eat savouries   Exception b 
16.0 Composite foods (e.g. casseroles, meat pies, mincemeat) – foods that could not be placed in categories 
01.0–15.0 
Food   
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The mTAMDI calculations are based on the normal use levels reported by Industry. The seven food 
categories used in the SCF TAMDI approach (SCF, 1995) correspond to the 18 food categories as 
outlined in Commission Regulation (EC) No 1565/2000 (EC, 2000) and reported by the Flavour 
Industry in the following way (see Table B.2.2): 
Beverages (SCF, 1995) correspond to food category 14.1 
Foods (SCF, 1995) correspond to the food categories 1, 2, 3, 4.1, 4.2, 6, 7, 8, 9, 10, 13, and/or 16] 
Exception a (SCF, 1995) corresponds to food category 5 and 11 
Exception b (SCF, 1995) corresponds to food category 15 
Exception c (SCF, 1995) corresponds to food category 14.2 
Exception d (SCF, 1995) corresponds to food category 12 
Exception e (SCF, 1995) corresponds to others, e.g. chewing gum. 
The candidate substance [FL-no. 16.121] is also anticipated to be used in chewing gum, which is not 
covered by any of the food categories in 1565/2000. Normal/maximum use levels for chewing gum are 
reported to be 10/25 mg/kg for [FL-no: 16.121]. For chewing gum, the intake estimate is 2 g/day. 
Under the assumptions that all of the flavouring substance is released from the chewing gum and that 
the intake estimate is 2 g chewing gum/day, the calculation of the mTAMDI of the candidate 
substance based on the 16 food categories and the use of chewing gum sum up to 670 µg/person/day, 
see Table B.2.3. 
Table B.2.3 Estimated intakes based on the mTAMDI approach 
FL-no EU Register name mTAMDI 
(µg/person/day) 
Structural 
class 
Threshold of 
concern 
(µg/person/day) 
16.121 Spilanthol 670 Class III 90 
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ABBREVIATIONS 
bw Body Weight 
CAS Chemical Abstract Service 
CEF Panel on Food Contact Materials, Enzymes, Flavourings and Processing Aids 
Chemical Abstract Service 
CoE Council of Europe 
EC European Commission 
EFFA European Flavour and Fragrance Association 
EFSA European Food Safety Authority 
EU European Union 
FAO Food and Agriculture Organization of the United Nations  
FEMA Flavor and Extract Manufacturers Association 
FGE Flavouring Group Evaluation  
FLAVIS (FL) Flavour Information System (database) 
ID Identity 
IOFI International Organization of the Flavour Industry 
IR Infrared spectroscopy 
JECFA The Joint FAO/WHO Expert Committee on Food Additives 
MS Mass spectrometry 
MSDI Maximised Survey-derived Daily Intake 
mTAMDI Modified Theoretical Added Maximum Daily Intake 
NMR Nuclear Magnetic Resonance 
No Number 
NOAEL No Observed Adverse Effect Level 
OECD Organisation for Economic Co-operation and Development 
SCF Scientific Committee on Food 
TAMDI Theoretical Added Maximum Daily Intake 
WHO World Health Organisation 
